Pharmaceutical Excipients: Properties, Functionality and Applications in Research and Industry (2017) Neerkin J, Brennan M, Jamal H. Use of opioids in patients with impaired renal function. In.: Nottingham, Engl: Palliativedrugs. com;2012. Kidny Disease Improving Global Outcomes. Blood pressure guideline. 2021; Available at: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2021-BP-GL.pdf. Accessed 10 November 2022.

Chang F, O’Hare AM, Miao Y, Steinman MA. Use of renally inappropriate medications in older veterans: a national study. J Am Geriatr Soc. 2015;63(11):2290–7. Sweileh WM, Janem SA, Sawalha AF, Abu-Taha AS, Zyoud SeH, Sabri IA, et al. Medication dosing errors in hospitalized patients with renal impairment: a study in Palestine. Pharmacoepidemiol Drug Saf. 2007;16(8):908–12. Physical Examination Procedures for Advanced Practitioners and Non-Medical Prescribers - 2nd ed. (2015) Roux-Marson C, Baranski JB, Fafin C, Exterman G, Vigneau C, Couchoud C. Medication burden and inappropriate prescription risk among elderly with advanced chronic kidney disease. BMC Geriatr. 2020;20(1):1–12. Pannu N, Nadim MK. An overview of drug-induced acute kidney injury. Crit Care Med. 2008;36(4):216–S223.Alahdal AM, Elberry AA. Evaluation of applying drug dose adjustment by physicians in patients with renal impairment. Saudi Pharm J. 2012;20(3):217–20.

Hassan Y, Al-Ramahi RJ, Aziz NA, Ghazali R. Drug use and dosing in chronic kidney disease. Ann Acad Med Singap. 2009;38(12):1095–103.Mason NA. Polypharmacy and medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20(5):492–7. Description: Drug dosing for different stages of renal insufficiency can be challenging. Patients can succumb to toxicities from inadequate clearance, resulting in accumulation of the drug metabolites and leading to increased vulnerability to adverse effects. This is a preventable state if clinicians have the knowledge, if not in detail, about drug pharmacokinetics/pharmacodynamics. This is the fifth edition of a handbook that provides well-structured guidance on prescribing drugs for patients with renal insufficiency and patients on renal replacement therapy. Akbar Z, Rehman S, Khan A, Khan A, Atif M, Ahmad N. Potential drug–drug interactions in patients with cardiovascular diseases: findings from a prospective observational study. J Pharm Policy Pract. 2021;14(1):1–9. The present study is a cross-sectional analytical study conducted at the nephrology outpatient department (OPD) of Sandeman Provincial Hospital (SPH) in Quetta, Balochistan. SPH is a large tertiary care hospital in the province, consisting of 800 beds and serving approximately 8000–10,000 patients daily [ 19, 20]. Study patients UK NCGC. : Investigating chronic kidney disease. Chronic Kidney Disease (Partial Update): Early Identification and Management of Chronic Kidney Disease in Adults in Primary and Secondary Care.edn.: National Institute for Health and Care Excellence (UK); 2014.

Saleem A, Masood I. Pattern and predictors of medication dosing errors in chronic kidney disease patients in Pakistan: a single center retrospective analysis. PLoS ONE. 2016;11(7):e0158677. Lameire NH, Levin A, Kellum JA, Cheung M, Jadoul M, Winkelmayer WC et al. Harmonizing acute and chronic kidney disease definition and classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2021;100(3):516–526. Kidny Disease Improving Global Outcomes. Anemia guideline. 2012; Available at: https://kdigo.org/wp-content/uploads/2016/10/KDIGO-2012-Anemia-Guideline-English.pdf. Accessed 20 November 2022.Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug–related morbidity and mortality. Ann Pharmacother. 2018;52(9):829–37.